The aim of this project is to develop a TPU-based nanocomposite filament containing nano-WO3 particles with a surface modified with APTES for the production of lead-free, flexible, and FFF-customizable radiotherapy shielding elements compatible with patient anatomy, for the protection of healthy tissues in clinical LINAC electron therapy, and to validate the sandwich shielding structures produced from this filament dosimetrically and anatomically under 6 and 9 MeV electron beams. The project aims to develop a flexible, patient-specific alternative that can be produced with FFF to overcome the toxicity, weight, customization difficulties, and clinical workflow limitations of traditional lead and Cerrobend-based shields used in electron therapy for lesions near the surface, such as non-melanoma skin cancers. While polymerbased radiation shielding systems with high atomic number additives have been studied in the literature, the FFF printability, microstructural homogeneity, sandwich shield architecture, and integrated dosimetric validation under clinical LINAC electron beams of a nano-WO3/TPU filament with an interface designed with APTES have not been addressed together. In this respect, the project presents a unique material-fabrication dosimetry approach that combines material design, additive manufacturing, medical physics, and
radiation oncology. The method will be carried out through five experimental work packages with interconnected outputs. In the first stage, nano-WO3 particles will be functionalized with APTES; surface modification will be verified by FTIR and TGA analyses. In the second stage, the modified particles will be mixed with a TPU matrix in a twin-screw microcompounder to produce high-fill masterbatch pellets; screw speed, mixing time, and temperature parameters will be evaluated in terms of dispersion quality. In the third stage, the masterbatch pellets will be diluted with pure TPU to convert them into filaments containing 30%, 50%, and 70% nano-WO3 by weight, with a diameter tolerance of 1.75 ± 0.05 mm; diameter stability, SEM/EDX mapping, agglomeration, porosity, and W distribution homogeneity will be investigated. In the fourth stage, the FFF processing window will be determined using TGA/DSC/MFI data and temperature, flow, and velocity tower tests; nozzle diameter, layer height, line width, nozzle temperature, printing speed, and flow rate will be optimized using Taguchi experimental design and ANOVA. In the final stage, sandwich shielding samples produced with optimum parameters will be evaluated under 6 and 9 MeV LINAC electron beams with EBT3 film and TLD measurements; under-shield transmission, surface dose, lateral dose profile, and penumbra will be measured, and patient-specific geometry will be verified in terms of contact surface, air gap, and repeated placement stability using 3D scanning on an anthropomorphic head phantom. The project will be carried out in five work packages over a 24-month period, utilizing the infrastructure of Erciyes University, Bartın University, Erciyes University Faculty of Medicine Hospitals, and Kayseri City Hospital. The project will contribute to the creation of an independent and interdisciplinary research pipeline by transferring the principal investigator's expertise in FFF-based polymer composite filaments, radiopaque materials, and phantom applications to clinical radiotherapy and medical physics validation processes. Expected outcomes
include a prototype of a domestically produced TPU/nano-WO3/silane composite filament, a validated FFF process recipe, a patient-specific shielding demonstration, SCI/SCI-E publications, conference presentations, a postgraduate thesis topic, patent potential, and preliminary data that will form the basis for TÜBİTAK 1001/1003 projects and international collaboration projects. The project outputs have the potential for scientific, technological, clinical, economic, and societal impact in terms of developing personalized, leadfree, and high-value-added radiotherapy accessories that can contribute to the preservation of healthy tissue.